Athanase Innovation AB
Athanase Innovation AB (publ) is public investment firm. The company invests in private and public technology and innovation companies. It also develops and sells machine inspection unit, used for automatic quality control, inspection and measurement of pallets. Athanase Innovation AB (publ) was founded in 2016 and is based in Stockholm, Sweden.
Athanase Innovation AB (ATIN) - Net Assets
Latest net assets as of September 2025: Skr435.84 Million SEK
Based on the latest financial reports, Athanase Innovation AB (ATIN) has net assets worth Skr435.84 Million SEK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr488.29 Million) and total liabilities (Skr52.45 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr435.84 Million |
| % of Total Assets | 89.26% |
| Annual Growth Rate | 97.82% |
| 5-Year Change | 12878.88% |
| 10-Year Change | N/A |
| Growth Volatility | 8572.03 |
Athanase Innovation AB - Net Assets Trend (2017–2025)
This chart illustrates how Athanase Innovation AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Athanase Innovation AB (2017–2025)
The table below shows the annual net assets of Athanase Innovation AB from 2017 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | Skr484.76 Million | -23.55% |
| 2024-06-30 | Skr634.09 Million | -19.93% |
| 2023-06-30 | Skr791.89 Million | -12.73% |
| 2022-06-30 | Skr907.40 Million | +24194.46% |
| 2021-06-30 | Skr3.73 Million | -98.47% |
| 2020-06-30 | Skr244.06 Million | -6.29% |
| 2019-06-30 | Skr260.43 Million | -5.88% |
| 2018-06-30 | Skr276.69 Million | +13284.59% |
| 2017-06-30 | Skr2.07 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Athanase Innovation AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 798278100.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr50.98 Million | 10.52% |
| Other Comprehensive Income | Skr-3.97 Million | -0.82% |
| Other Components | Skr437.75 Million | 90.30% |
| Total Equity | Skr484.76 Million | 100.00% |
Athanase Innovation AB Competitors by Market Cap
The table below lists competitors of Athanase Innovation AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Patagonia Gold Corp
PINK:HGLD
|
$6.52 Million |
|
Americore Resources Corp.
V:AMCO
|
$6.53 Million |
|
Ras Technology Holdings Ltd
AU:RTH
|
$6.53 Million |
|
Harte Hanks Inc
NASDAQ:HHS
|
$6.53 Million |
|
Rand Capital Corp
NASDAQ:RAND
|
$6.52 Million |
|
Viveon Health Acquisition Corp
NYSE MKT:VHAQ
|
$6.52 Million |
|
Nexalin Technology Inc.
NASDAQ:NXL
|
$6.52 Million |
|
Chibougamau Independent Mines Inc
PINK:CMAUF
|
$6.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Athanase Innovation AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 634,086,000 to 484,761,000, a change of -149,325,000 (-23.5%).
- Net loss of 19,640,000 reduced equity.
- Share repurchases of 129,304,000 reduced equity.
- Other comprehensive income decreased equity by 153,716,000.
- Other factors increased equity by 153,335,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-19.64 Million | -4.05% |
| Share Repurchases | Skr129.30 Million | -26.67% |
| Other Comprehensive Income | Skr-153.72 Million | -31.71% |
| Other Changes | Skr153.34 Million | +31.63% |
| Total Change | Skr- | -23.55% |
Book Value vs Market Value Analysis
This analysis compares Athanase Innovation AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.78x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.08x to 0.78x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-06-30 | Skr14.76 | Skr15.90 | x |
| 2019-06-30 | Skr13.89 | Skr15.90 | x |
| 2020-06-30 | Skr13.02 | Skr15.90 | x |
| 2021-06-30 | Skr0.15 | Skr15.90 | x |
| 2022-06-30 | Skr29.23 | Skr15.90 | x |
| 2023-06-30 | Skr25.51 | Skr15.90 | x |
| 2024-06-30 | Skr21.30 | Skr15.90 | x |
| 2025-06-30 | Skr20.40 | Skr15.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Athanase Innovation AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.05%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -11.11%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 1.14x
- Recent ROE (-4.05%) is above the historical average (-32.17%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 2.56% | 17.22% | 0.06x | 2.57x | Skr-20.58 Million |
| 2019 | 2.42% | 15.00% | 0.06x | 2.67x | Skr-19.74 Million |
| 2020 | 2.54% | 14.59% | 0.06x | 2.77x | Skr-18.22 Million |
| 2021 | -234.54% | 0.00% | 0.00x | 1.04x | Skr-9.13 Million |
| 2022 | -2.93% | -376.06% | 0.01x | 1.01x | Skr-117.29 Million |
| 2023 | -14.46% | -1794.86% | 0.01x | 1.04x | Skr-193.72 Million |
| 2024 | -8.87% | -138.58% | 0.06x | 1.08x | Skr-119.67 Million |
| 2025 | -4.05% | -11.11% | 0.32x | 1.14x | Skr-68.12 Million |
Industry Comparison
This section compares Athanase Innovation AB's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $2,837,980,556
- Average return on equity (ROE) among peers: 6.73%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Athanase Innovation AB (ATIN) | Skr435.84 Million | 2.56% | 0.12x | $6.52 Million |
| BMC (BMC) | $46.31 Million | 81.79% | 0.68x | $8.84 Million |
| Bure Equity AB (BURE) | $13.57 Billion | 31.15% | 0.02x | $1.09 Billion |
| Case Group AB (CASE) | $288.95 Million | 5.93% | 0.23x | $16.50 Million |
| Catella AB A (CAT-A) | $932.00 Million | -2.36% | 2.74x | $77.53 Million |
| Catella AB (publ) (CAT-B) | $932.00 Million | -2.36% | 2.74x | $75.92 Million |
| Creades AB (CRED-A) | $9.18 Billion | 6.08% | 0.02x | $335.82 Million |
| Effnetplattformen Holding AB (EFFH) | $16.30 Million | -31.51% | 0.16x | $4.04K |
| First Venture Sweden AB Series B (FIRST-B) | $165.81 Million | -7.93% | 0.02x | $3.11 Million |
| Flat Capital AB Series B (FLAT-B) | $412.76 Million | -20.20% | 0.00x | $61.10 Million |